# ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

> **NCT00496379** · PHASE2 · TERMINATED · sponsor: **Nancy Lin, MD** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer
- CNS Disease

## Interventions

- **DRUG:** ZK219477

## Key facts

- **NCT ID:** NCT00496379
- **Lead sponsor:** Nancy Lin, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-10
- **Final completion:** 2012-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** This study has closed to accrual early due to slow accrual.
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496379, "ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00496379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*